Roxane Recalls Calcitriol Oral Solution Due to Impurity Issues
Boehringer Ingelheim Roxane Inc recalls specific lots of Calcitriol Oral Solution 1 mcg/mL due to failed impurity specifications.
Recall notice
Failed Impurity/Degradation Specification; out of specification for trans-calcitriol degradant at the 9 month stability time point
Contact the company
What happened, in plain English
Boehringer Ingelheim Roxane Inc is recalling Calcitriol Oral Solution 1 mcg/mL in 15mL bottles because the product failed impurity and degradation specifications. Specifically, the recall addresses out-of-specification levels of trans-calcitriol degradant at the 9-month stability time point. The affected product was distributed nationwide. Read more at govinfonow.com/recall/46100-boehringer-ingelheim-roxane-inc-recalls-calcitriol-oral-solution-1-mcg.
Source Summary by GovInfoNow · govinfonow.com/recall/46100-boehringer-ingelheim-roxane-inc-recalls-calcitriol-oral-solution-1-mcg · Updated October 13, 2026 · FDA enforcement record: FDA #D-1427-2014
Cite this page
“Roxane Recalls Calcitriol Oral Solution Due to Impurity Issues.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46100-boehringer-ingelheim-roxane-inc-recalls-calcitriol-oral-solution-1-mcg. Based on FDA recall #D-1427-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1427-2014%22&limit=1).
Why it’s dangerous
The product failed to meet specifications for trans-calcitriol degradant at the 9-month stability time point. The record does not describe specific injuries or health risks associated with this impurity level.
Who’s affected
Patients who have been prescribed Calcitriol Oral Solution from Roxane Laboratories, Inc., specifically those with bottles containing Lot # 360122A and an expiration date of May 2015.
How to tell if you have this one
Check if you have Calcitriol Oral Solution 1 mcg/mL in a 15mL bottle manufactured by Roxane Laboratories, Inc. Look for NDC 0054-3120-41, Lot # 360122A, and an expiration date of May 2015.
- Brand
Roxane- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 11 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1427-2014 (May 1, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1427-2014 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.